Dry Eye Disease (DED) is a common condition that affects, by region, between 5% and 15% of the population, with a prevalence correlated with age. The conditions of modern life -daily computer work, driving, artificial light, air pollution, contact lens wearing- make this condition troublesome and more and more frequent.
Through years of R&D, an update was conducted around the effective treatment of Meibomian Gland Dysfunction. Based on that a new treatment has been elaborated and not only through a symptomatic approach. This treatment is also the subject of clinical trials demonstrating excellent results.
Before treatment, the eye mask (opaque eye protection) is placed on the patient's eyes. The optical gel -supplied with the device- is applied thickly in the area below the inferior lid from cheekbones to the temporal region.
A series of 5 flashes -IRPL (Intense Regulated Pulsed Light)- is performed under each eye (from nasal to temporal region). A second session must be made two weeks after the first one, after which a gap of one month is recommended between the following sessions. The treated region is an area where the parasympathetic nerve is anatomically connected to the meibomian glands by a set of second branches.
The observed effect is cumulative throughout the sessions and the return to a normal activity of the Meibomian Glands depends on the grade of dry eye: